Breakthrough May Lead To Diagnosing Living Players With CTE

In one of the “biggest breakthroughs to date,” researchers from the Boston Univ. School of Medicine have “discovered a key biomarker" for CTE that they "hope marks the first step toward being able to diagnose and ultimately treat the neurodegenerative disease in a living football player.” Dr. Ann McKee said it is “the first ray of hope" in a years-long effort to understand the disease. She “cautioned that a lot more research is needed.” Researchers are “hopeful that if an elevated biomarker in a living person might indicate the presence of CTE, research into prevention and treatment of the disease can begin to move forward” (WASHINGTONPOST.com, 9/26).